Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report

RATIONALE: Patients reporting high PD-L1 expression have shown to respond well to immunotherapy; however, some patients develop hyperprogressive disease upon initiation of immune checkpoint inhibitors. We report a patient with lung cancer and 100% PD-L1 expression who developed hyperprogressive dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Fricke, Jeremy, Mambetsariev, Isa, Pharaon, Rebecca, Subbiah, Shanmuga, Rajurkar, Swapnil, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668523/
https://www.ncbi.nlm.nih.gov/pubmed/33181636
http://dx.doi.org/10.1097/MD.0000000000022323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668523/
https://www.ncbi.nlm.nih.gov/pubmed/33181636
http://dx.doi.org/10.1097/MD.0000000000022323

Ejemplares similares